AF
LTRN icon

Allworth Financial’s Lantern Pharma LTRN Stock Holding History

Allworth Financial’s Portfolio LTRN Stock Details LTRN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q4 		– Sell
-2,100
Closed -$9.13K – 5181
2025
Q3 		$9.13K Buy
2,100
+2,000
+2,000% +$8.35K ﹤0.01% 3200
2025
Q2 		$316 Hold
100
– – ﹤0.01% 4237
2025
Q1 		$362 Hold
100
– – ﹤0.01% 3761
2024
Q4 		$448 Hold
100
– – ﹤0.01% 3630
2024
Q3 		$367 Hold
100
– – ﹤0.01% 3489
2024
Q2 		$441 Hold
100
– – ﹤0.01% 3409
2024
Q1 		$880 Hold
100
– – ﹤0.01% 3123
2023
Q4 		$428 Hold
100
– – ﹤0.01% 3168
2023
Q3 		$341 Hold
100
– – ﹤0.01% 3132
2023
Q2 		$564 Hold
100
– – ﹤0.01% 2874
2023
Q1 		$483 Buy
+100
New +$525 ﹤0.01% 2847

Other funds holding LTRN

BCM
BIOS Capital Management Fort Worth, Texas $52.9M AUM 30.51% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
CM
CM Management Gulf Breeze, Florida $120M AUM 37.12% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
VC
Voss Capital Houston, Texas $1.88B AUM 1.03% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
NA
NewEdge Advisors New Orleans, Louisiana $27.7B AUM 22.98% 1-Year Est. Return
WIM
Westside Investment Management Santa Monica, California $761M AUM 39.85% 1-Year Est. Return

Allworth Financial's LTRN Position: Q4 2025 in Review

Allworth Financial sold out of Lantern Pharma (LTRN) in Q4 2025, closing a stake of 2,100 shares — an estimated $9.13K sold.

Allworth Financial first reported a position in LTRN in Q1 2023 and held it in 11 quarters. The position peaked at $9.13K in Q3 2025. 33 funds tracked by Wall St. Rank hold LTRN as of Q4 2025.

  • Allworth Financial reported no remaining Lantern Pharma position as of Q4 2025 after selling out during the quarter.
  • Allworth Financial sold 2,100 Lantern Pharma shares in Q4 2025, an estimated $9.13K.
  • Allworth Financial first reported a position in Lantern Pharma in Q1 2023 and held it in 11 quarters.
  • Allworth Financial's Lantern Pharma position peaked at $9.13K in Q3 2025.
  • 33 funds tracked by Wall St. Rank held Lantern Pharma as of Q4 2025.

Based on Allworth Financial's 13F filing for Q4 2025, filed 5 Feb 2026.